Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

    July 2019 in “ PloS one ”
    Fatma N Hamed, Annika Åstrand, Marta Bertolini, Alfredo Rossi, Afsaneh Maleki-Dizaji, A.G. Messenger, A.J.G. McDonagh, Rachid Tazi-Ahnini
    Image of study
    TLDR Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.
    The study investigated the role of T regulatory cells (Tregs) in Alopecia Areata (AA) by comparing 20 AA patients with active hair loss to 15 healthy subjects. It found a significant reduction in the Treg suppressor HLA-DR+ subpopulation and CD39+ cells among the CD4+CD25+Foxp3+ Treg subpopulation in AA patients. Specifically, FOXP3+CD39+ Treg cells were reduced by 75% in non-lesional skin and 90% in lesional skin of AA patients. Additionally, the study identified unique Treg clonotypes in healthy individuals that were absent in AA patients, suggesting a protective role. The findings suggest that the deficiency of these Treg cells may contribute to the disease process and that targeting CD39 expression on T-cells could be a potential therapeutic approach. The study also noted a clonotypic restriction in the Treg TCRβ-chain in AA patients, indicating a less diverse TCR repertoire, which could be involved in the pathogenesis of AA.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Binding affinity of pyrilutamide!

      in Update  167 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community Why I deleted my YouTube channel Part I

      in Update  118 upvotes 3 years ago
      A YouTuber named Kevin, also known as Rider_Of_Roach, who deleted his YouTube channel due to personal attacks and controversy surrounding his views on hair loss treatments. He advocated for FDA-approved treatments like finasteride and minoxidil but faced backlash from those who disagreed with him. The conversation also discusses his past trolling behavior and a lawsuit he filed against a website that published false information about him. Despite some disagreements, many viewers appreciated his research-based content and hope to see him return in the future.

      community Only Minoxidil 2 Months Before After Photos

      in Progress Pictures  132 upvotes 8 months ago
      A user shared their 2-month hair growth progress using only Minoxidil, noting significant improvement and plans to continue despite a genetic predisposition to baldness. They apply Minoxidil twice daily, experienced a heat rash, and chose not to use Finasteride due to side effects.

    Related Research

    3 / 3 results